secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0001193125-23-110686
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD sets combined 2022/2023 annual meeting for June 19, 2023
-----------------------------------------------------------------------

- Annual meeting set for June 19, 2023; record date April 20, 2023 (past).
- Company did not hold a 2022 annual meeting; 2022 and 2023 meetings combined.
- Deadline for Rule 14a-8 shareholder proposals is May 1, 2023.
- Deadline for director nominations and universal proxy notices also May 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312523110686/0001193125-23-110686-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312523110686/d473325d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-110686

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer